Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Alzamend Neuro, Inc. (ALZN) had Cash Flow from Financial Activities of $10.44M for the most recently reported fiscal quarter, ending 2025-04-30.
| Income Statement Financials | |
-- |
|
$-1.68M |
|
-- |
|
-- |
|
$1.14M |
|
$-1.14M |
|
$-0.00M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.14M |
|
$-1.13M |
|
0.45M |
|
0.45M |
|
$5.24 |
|
$5.24 |
|
| Balance Sheet Financials | |
$4.18M |
|
$0.43M |
|
$0.43M |
|
$4.60M |
|
$0.63M |
|
-- |
|
-- |
|
$0.63M |
|
$3.97M |
|
$3.97M |
|
$3.97M |
|
0.78M |
|
| Cash Flow Statement Financials | |
$-6.57M |
|
$-0.30M |
|
|
Cash Flow from Financial Activities |
$10.44M |
$0.38M |
|
$3.95M |
|
$3.57M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.87M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-28.71% |
|
-28.71% |
|
-24.75% |
|
-28.71% |
|
$5.10 |
|
$-15.24 |
|
$-14.57 |
|